wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33414487-17682022-4CA0-46A8-BA1E-D660934AA2F5
Q33414487-17682022-4CA0-46A8-BA1E-D660934AA2F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414487-17682022-4CA0-46A8-BA1E-D660934AA2F5
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.
P1476
Q33414487-17682022-4CA0-46A8-BA1E-D660934AA2F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414487-17682022-4CA0-46A8-BA1E-D660934AA2F5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a068da825544b68c2282b5bcb3a798db7f5f1575
P1476
Bosutinib efficacy and safety
......
e: Minimum 24-month follow-up.
@en